erdosteine has been researched along with HIV Coinfection in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carlson, JM; Deng, W; deSouza, MS; Dommaraju, K; Edlefsen, PT; Geraghty, DE; Kaewkungwal, J; Kijak, G; Kim, JH; Larsen, BB; Maust, BS; Michael, NL; Mullins, JI; Nitayaphan, S; O'Connell, RJ; Pitisuttihum, P; Ratto-Kim, S; Rerks-Ngarm, S; Robb, ML; Rolland, M; Sanders-Buell, E; Tovanabutra, S | 1 |
1 trial(s) available for erdosteine and HIV Coinfection
Article | Year |
---|---|
CD8 and CD4 epitope predictions in RV144: no strong evidence of a T-cell driven sieve effect in HIV-1 breakthrough sequences from trial participants.
Topics: Adolescent; Adult; AIDS Vaccines; Alleles; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Epitopes, T-Lymphocyte; Female; gag Gene Products, Human Immunodeficiency Virus; Genotype; HIV Envelope Protein gp120; HIV Infections; HIV-1; HLA Antigens; Humans; Male; Proteome; Thioglycolates; Thiophenes; Young Adult | 2014 |